NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 118)
Posted On: 12/13/2018 5:31:08 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) New Management Hire to Drive Revenue Growth, Advance Commercialization Programs
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, recently named Dr. Bradford A. Young as its senior vice president and chief commercial officer. An article discussing the company’s recent appointment reads, “Young joins the Pressure BioSciences management team with a solid entrepreneurial background and the experience of providing executive level consulting for strategic planning, product development and commercialization to various biomedical, diagnostic and pharmaceutical companies. In his new position as senior vice president and chief commercial officer, he will play a critical role in advancing the company’s commercialization programs and overall strategic planning, with a view toward establishing new and/or enhanced revenue opportunities and significant partnerships. … More specifically, Young will promote the company’s instruments, consumables and technology platforms with synergistic companies worldwide, with a goal of integrating Pressure BioSciences’ products into their offerings. These types of collaborations and partnerships could result in major volume sales, enabling the company to significantly boost its revenue.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, recently named Dr. Bradford A. Young as its senior vice president and chief commercial officer. An article discussing the company’s recent appointment reads, “Young joins the Pressure BioSciences management team with a solid entrepreneurial background and the experience of providing executive level consulting for strategic planning, product development and commercialization to various biomedical, diagnostic and pharmaceutical companies. In his new position as senior vice president and chief commercial officer, he will play a critical role in advancing the company’s commercialization programs and overall strategic planning, with a view toward establishing new and/or enhanced revenue opportunities and significant partnerships. … More specifically, Young will promote the company’s instruments, consumables and technology platforms with synergistic companies worldwide, with a goal of integrating Pressure BioSciences’ products into their offerings. These types of collaborations and partnerships could result in major volume sales, enabling the company to significantly boost its revenue.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼